Malevolent alliance of MYBL2hi cancer stem cell and SPP1+ macrophage confers resistance to neoadjuvant immunotherapy in bladder cancer

QR Code

Malevolent alliance of MYBL2hi cancer stem cell and SPP1+ macrophage confers resistance to neoadjuvant immunotherapy in bladder cancer

Background Neoadjuvant immune checkpoint blockade (nICB) has revolutionized cancer treatment, yet the underlying mechanisms of resistance in bladder cancer remain to be explored.Methods We conducted single-cell RNA sequencing (scRNA-seq) on peripheral blood mononuclear cells, tumor tissues, adjacent...

Full description

Saved in:

Bibliographic Details
Main Authors:	Lin Ma, Jie Dong, Yingjie Li, Xuebin Zhang, Ziyi Li, Hualin Chen, Yi Xie, Zhaoheng Jin, Yueqiang Peng, Zhigang Ji
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2025-07-01
Series:	Journal for ImmunoTherapy of Cancer
Online Access:	https://jitc.bmj.com/content/13/7/e011319.full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Neoadjuvant chemotherapy of invasive bladder cancer
by: S. N. Isayeva, et al.
Published: (2012-04-01)

Significance of tumor-associated macrophages in bladder cancer development
by: V. N. Pavlov, et al.
Published: (2022-10-01)

Behavioral Features of Negative and Malevolent Creativity in Adolescents
by: Bochkova M.N., et al.
Published: (2019-05-01)

NEOADJUVANT CHEMOTHERAPY WITH RADICAL CYSTECTOMY IN THE TREATMENT OF MUSCLE-INVASIVE BLADDER CANCER
by: N. S. Nurgaliev, et al.
Published: (2016-10-01)

Interrelation of Malevolent Creativity and Values in Adolescents with Different Levels of Aggression
by: Meshkova N.V.
Published: (2018-10-01)

Hemocyanins in the Immunotherapy of Superficial Bladder Cancer
by: Arancibia, Sergio, et al.
Published: (2012)

The role of exosomes in bladder cancer immunotherapy
by: Mohammad Mousaei Ghasroldasht, et al.
Published: (2025-06-01)

Cost-effectiveness of perioperative durvalumab plus neoadjuvant chemotherapy for muscle invasive bladder cancer in the United States
by: Caicong You, et al.
Published: (2025-07-01)

Complete regress of a low-differentiated recurrence of the bladder cancer as the answer on two cycles of neoadjuvant polychemotherapy
by: P. G. Yakovlev, et al.
Published: (2020-05-01)

Neoadjuvant Therapy in Breast Cancer
by: Traylor, Angela Lewis, et al.
Published: (2012)

Neoadjuvant Chemotherapy in Gynecologic Cancers
by: Suprasert, Prapaporn
Published: (2012)

Neoadjuvant Chemotherapy in Ovarian Cancer
by: Singh, Jasmeet Chadha, et al.
Published: (2012)

Neoadjuvant treatment for breast cancer
by: V. F. Semiglazov, et al.
Published: (2014-07-01)

Breast Cancer: Neoadjuvant Chemotherapy
by: Barbara F. Shea, et al.
Published: (2015-05-01)

Breast Cancer: Neoadjuvant Chemotherapy
by: Barbara F. Shea, et al.
Published: (2007-03-01)

Breast Cancer: Neoadjuvant Chemotherapy
by: Barbara F. Shea, et al.
Published: (2015-05-01)

Breast Cancer: Neoadjuvant Chemotherapy
by: Barbara F. Shea, et al.
Published: (2007-03-01)

IMMUNOTHERAPY BASED ON DENDRITIC CELLS IN BLADDER CANCER TREATMENT
by: A. S. Ilnitskaya, et al.
Published: (2018-07-01)

Schistosomasis and Bladder Cancer
by: Eissa, Saad S., et al.
Published: (2012)

Bladder Cancer Biology
by: Fuessel, Susanne, et al.
Published: (2012)

Effects of the Number of Neoadjuvant Cycles and Addition of Adjuvant Chemotherapy on the Prognosis of Muscle‐Invasive Bladder Cancer Treated With Radical Cystectomy
by: Shingo Hatakeyama, et al.
Published: (2025-05-01)

Advancements in bladder cancer immunotherapy: a focus on intravesical approaches
by: Xia Tang, et al.
Published: (2025-07-01)

Newcastle disease virus - effective alliance in the fight against cancer
by: A. O. Sitkovskaya, et al.
Published: (2019-01-01)

Neoadjuvant Systemic Therapy in Breast Cancer
by: Semiglazov, Vladimir F., et al.
Published: (2012)

Neoadjuvant Chemotherapy in the Treatment of Cervical Cancer
by: Eiriksson, Lua, et al.
Published: (2012)

Neoadjuvant Treatment for Oesophago-Gastric Cancer
by: Anderson, John E., et al.
Published: (2012)

The HiSCORE Project
by: M. Tluczykont, et al.
Published: (2014-12-01)

Field dependent-independent cognitive style as a predictor of malevolent creativity: a multifaceted approach
by: Pierpaolo Zivi, et al.
Published: (2025-07-01)

The Connotation of "Dispelling Xiegui (Malevolent Pathogenic Influences)" in the Shennong's Classic of Materia Medica and the Study on Medication
by: Shujia YANG, et al.
Published: (2025-05-01)

Epigenetic Biomarkers in Bladder Cancer
by: Zimbardi, Daniela, et al.
Published: (2012)

Angiogenesis and Lymphangiogenesis in Bladder Cancer
by: Miyata, Yasuyoshi, et al.
Published: (2012)

Identification and Evaluation of the Urinary Microbiota Associated With Bladder Cancer
by: Nannan Li, et al.
Published: (2025-08-01)

Genome-wide identification of MYBL2 in Brassicaceae, with a focus on the expression pattern of regulating anthocyanin synthesis in Brassica crops
by: Chenchen Wang, et al.
Published: (2025-07-01)

Developments in Neoadjuvant Chemotherapy and Radiotherapy in Rectal Cancer
by: Conde, Sofia, et al.
Published: (2012)

Taxanes in adjuvant and neoadjuvant therapy for breast cancer
by: S. V. Limareva
Published: (2014-08-01)

Modern principles of neoadjuvant therapy for rectal cancer
by: A. M. Karachun, et al.
Published: (2025-05-01)

NEOADJUVANT CHEMOTHERAPY FOR LOCALLY ADVANCED CERVICAL CANCER
by: O. N. Churuksaeva, et al.
Published: (2016-02-01)

Neoadjuvant personalized cancer vaccines: the final frontier?
by: Guilhem Richard, et al.
Published: (2024-12-01)

CD4+ skin resident memory T cells preferentially colocalize with dermal Folr2hi macrophages in contact hypersensitivity
by: Akihiko Murata, et al.
Published: (2025-07-01)

Molecular genetic subtypes of bladder cancer
by: S. V. Kotov, et al.
Published: (2023-10-01)